Pair Name | Betulinic Acid, Gemcitabine | ||
Phytochemical Name | Betulinic Acid (PubChem CID: 64971 ) | ||
Anticancer drug Name | Gemcitabine (PubChem CID: 60750 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Betulinic Acid, Gemcitabine | |||
Disease Info | [ICD-11: 2A00-2F9Z] | Solid tumour or cancer | Investigative | |
Gene Regulation | Down-regulation | Phosphorylation | CHEK1 | hsa1111 |
Down-regulation | Phosphorylation | RPA2 | KEGG ID N.A. | |
In Vitro Model | BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0186 |
NCI-H1299 | Lung large cell carcinoma | Homo sapiens (Human) | CVCL_0060 | |
HEK293T | Healthy | Homo sapiens (Human) | CVCL_0063 | |
In Vivo Model | To establish tumor xenograft, exponentially growing mCherry-BxPC-3 cells were mixed at a 2:1 ratio with Matrigel (Becton Dickinson, Bedford, MA) and a 200 μL suspension containing 5×10⁶ cells was subcutaneously inoculated into the right flank of each mouse. | |||
Result | These data provide evidence that betulinic acid is a potential candidate for chemosensitization as a naturally occurring Chk1 inhibitor and warrants further preclinical evaluation. |
No. | Title | Href |
---|---|---|
1 | Betulinic acid, a major therapeutic triterpene of Celastrus orbiculatus Thunb., acts as a chemosensitizer of gemcitabine by promoting Chk1 degradation. J Ethnopharmacol. 2023 Jun 12;309:116295. doi: 10.1016/j.jep.2023.116295. | Click |